Growth Metrics

TrueBlue (TBI) EBIT (2016 - 2025)

TrueBlue (TBI) has disclosed EBIT for 17 consecutive years, with -$29.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT fell 182.84% to -$29.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$46.6 million, a 49.73% increase, with the full-year FY2025 number at -$46.6 million, up 49.73% from a year prior.
  • EBIT was -$29.4 million for Q4 2025 at TrueBlue, down from -$146000.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $29.3 million in Q2 2022 to a low of -$60.0 million in Q2 2024.
  • A 5-year average of -$1.1 million and a median of -$2.8 million in 2023 define the central range for EBIT.
  • Peak YoY movement for EBIT: surged 189.22% in 2021, then crashed 814.58% in 2024.
  • TrueBlue's EBIT stood at $22.0 million in 2021, then crashed by 68.77% to $6.9 million in 2022, then crashed by 225.77% to -$8.6 million in 2023, then decreased by 20.61% to -$10.4 million in 2024, then crashed by 182.84% to -$29.4 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's EBIT are -$29.4 million (Q4 2025), -$146000.0 (Q3 2025), and -$2.9 million (Q2 2025).